HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prophylactic erythropoietin exacerbates ventilation-induced lung inflammation and injury in preterm lambs.

Abstract
Ventilation-induced lung injury (VILI) of preterm neonates probably contributes to the pathogenesis of bronchopulmonary dysplasia (BPD). Erythropoietin (EPO) has been suggested as a therapy for BPD. The aim of this study was to determine whether prophylactic administration of EPO reduces VILI in preterm newborn lambs. Lambs at 126 days of gestation (term is 147 days) were delivered and ventilated with a high tidal volume strategy for 15 min to cause lung injury, then received gentle ventilation until 2 h of age. Lambs were randomized to receive intravenous EPO (5000 IU kg(-1): Vent+EPO; n = 6) or phosphate-buffered saline (Vent; n = 7) soon after birth: unventilated controls (UVC; n = 8) did not receive ventilation or any treatment. Physiological parameters were recorded throughout the experimental procedure. Samples of lung were collected for histological and molecular assessment of inflammation and injury. Samples of liver were collected to assess the systemic acute phase response. Vent+EPO lambs received higher F IO 2, P aO 2 and oxygenation during the first 10 min than Vent lambs. There were no differences in physiological indices beyond this time. Total lung injury score, airway wall thickness, inflammation and haemorrhage were higher in Vent+EPO lambs than in Vent lambs. Lung inflammation and early markers of lung and systemic injury were elevated in ventilated lambs relative to unventilated lambs; EPO administration further increased lung inflammation and markers of lung and systemic injury. Prophylactic EPO exacerbates VILI, which may increase the incidence and severity of long-term respiratory disease. More studies are required before EPO can be used for lung protection in preterm infants.
AuthorsGraeme R Polglase, Samantha K Barton, Jacqueline M Melville, Valerie Zahra, Megan J Wallace, Melissa L Siew, Mary Tolcos, Timothy J M Moss
JournalThe Journal of physiology (J Physiol) Vol. 592 Issue 9 Pg. 1993-2002 (May 01 2014) ISSN: 1469-7793 [Electronic] England
PMID24591575 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Erythropoietin
Topics
  • Animals
  • Animals, Newborn
  • Erythropoietin (administration & dosage, adverse effects)
  • Female
  • Humans
  • Lung Injury (chemically induced, etiology, pathology)
  • Pneumonia (chemically induced, etiology, pathology)
  • Pregnancy
  • Random Allocation
  • Respiration, Artificial (adverse effects)
  • Sheep, Domestic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: